Active ingredientNadololCat. No. P-N003-002CAS 42200-33-9Family · Pharmaceutical analytical standards
Nadolol
A non-selective beta blocker patented in 1970 and in use since 1978: it is used for hypertension and angina pectoris and to prevent some arrhythmias. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Unlike many beta blockers it is not processed by the liver: it leaves the body unchanged, in urine and faeces, and its half-life can reach about 24 hours.
Active ingredientNadololCat. No. P-N003-002CAS 42200-33-9
Pharmacopoeial impurityNadolol EP Impurity A (Mixture of Diastereomers)Cat. No. P-N003-003
Pharmacopoeial impurityNadolol EP Impurity D (Mixture of Diastereomers)Cat. No. P-N003-004
Pharmacopoeial impurityNadolol EP Impurity E (Mixture of Diastereomers)Cat. No. P-N003-006CAS 2434865-25-3
Pharmacopoeial impurityNadolol EP Impurity F HydrochlorideCat. No. P-N003-007CAS 15230-34-9
Pharmacopoeial impurityNadolol EP Impurity FCat. No. P-N003-008CAS 2116-22-5
Pharmacopoeial impurityNadolol EP Impurity G HydrochlorideCat. No. P-N003-009CAS 15148-92-2
Pharmacopoeial impurityNadolol EP Impurity GCat. No. P-N003-010CAS 33841-03-1
Isotopically labelledNadolol-d5Cat. No. P-N003-011
Isotopically labelledNadolol-d9 (Mixture of Diastereomers)Cat. No. P-N003-012CAS 1432056-38-6
NitrosamineN-NitrosonadololCat. No. P-N003-013CAS 134720-06-2
Impurity2S,3R,2'S-NadololCat. No. P-N003-015CAS 54933-35-6
ImpurityNadolol Impurity 1Cat. No. P-N003-016CAS 685850-87-7
ImpurityNadolol Epoxide ImpurityCat. No. P-N003-017CAS 35697-15-5
ImpurityNadolol Impurity 2Cat. No. P-N003-018
ImpurityNadolol EP Impurity C (Mixture of Diastereomers)Cat. No. P-N003-020No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceNadolol CRSEDQM code Y0000146Family NadololNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.